NALTORIX Trademark Information
Number:
2555050
Words:
NALTORIX
Kind:
Word
Status group:
REGISTERED
Status code:
Registered
Status detail:
Registered/protected
Priority date:
11 Jun 2025
Lodgement date:
11 Jun 2025
First report date:
25 Jun 2025
Acceptance date:
02 Jan 2026
Acceptance advertised date:
02 Jan 2026
Entered on register date:
10 Mar 2026
Registered from date:
11 Jun 2025
Registration advertised date:
10 Mar 2026
Renewal due date:
11 Jun 2035
Filing date:
11 Jun 2025
Indexing constituents:
NALTORIXClass:
5
Mark categories:
Trademark
Registration date:
2026-03-10
Last status check:
2026-06-19 23:54:19
Status updated at:
2026-06-19 23:54:19
Goods and services:
1) Class: 5Description: Pharmaceutical drugs, namely, drugs in tablet form containing opioid receptor antagonists related to normorphine
History and publication details:
1) Date: 2026-03-10
Display name: IP Right Registered correspondence sent
2) Date: 2026-03-10
Display name: IP Right Registration Published
3) Date: 2026-03-10
Display name: Status change to Registered/Protected
4) Date: 2026-01-02
Display name: Application Accepted correspondence sent
5) Date: 2026-01-02
Display name: IP Right has been Examined
6) Date: 2026-01-02
Display name: IP Right Acceptance Published
7) Date: 2026-01-02
Display name: Status change to Accepted
8) Date: 2026-01-02
Display name: IP right goods and service classes updated
Description: Class Count: 1 Class Numbers:5
Previous details: Class Count: 1 Class Numbers: 5
New details: Class Count: 1 Class Numbers: 5
9) Date: 2026-01-02
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details: Class Number: 5 Class Items: pharmaceutical drugs
New details: Class Number: 5 Class Items: Pharmaceutical drugs, namely, drugs in tablet form containing opioid receptor antagonists related to normorphine
10) Date: 2025-11-27
Display name: Examination Response Received
11) Date: 2025-11-13
Display name: Customer Amendment Made correspondence sent
12) Date: 2025-11-13
Display name: Customer Amendment Made correspondence sent
13) Date: 2025-11-12
Display name: Amendment to Address for Service Requested
14) Date: 2025-06-25
Display name: Adverse Report (Examination) correspondence sent
15) Date: 2025-06-25
Display name: IP Right has been Examined
16) Date: 2025-06-11
Display name: IP Right Filed correspondence sent
17) Date: 2025-06-11
Display name: Awaiting examination
18) Date: 2025-06-11
Display name: Examination expedited
19) Date: 2025-06-11
Display name: IP Right Filed Published
20) Date: 2025-06-11
Display name: Status change to Published
21) Date: 2025-06-11
Display name: Status change to Filed
22) Date: 2025-06-11
Display name: Trade mark representation updated
23) Date: 2025-06-11
Display name: Application Received
Display name: IP Right Registered correspondence sent
2) Date: 2026-03-10
Display name: IP Right Registration Published
3) Date: 2026-03-10
Display name: Status change to Registered/Protected
4) Date: 2026-01-02
Display name: Application Accepted correspondence sent
5) Date: 2026-01-02
Display name: IP Right has been Examined
6) Date: 2026-01-02
Display name: IP Right Acceptance Published
7) Date: 2026-01-02
Display name: Status change to Accepted
8) Date: 2026-01-02
Display name: IP right goods and service classes updated
Description: Class Count: 1 Class Numbers:5
Previous details: Class Count: 1 Class Numbers: 5
New details: Class Count: 1 Class Numbers: 5
9) Date: 2026-01-02
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details: Class Number: 5 Class Items: pharmaceutical drugs
New details: Class Number: 5 Class Items: Pharmaceutical drugs, namely, drugs in tablet form containing opioid receptor antagonists related to normorphine
10) Date: 2025-11-27
Display name: Examination Response Received
11) Date: 2025-11-13
Display name: Customer Amendment Made correspondence sent
12) Date: 2025-11-13
Display name: Customer Amendment Made correspondence sent
13) Date: 2025-11-12
Display name: Amendment to Address for Service Requested
14) Date: 2025-06-25
Display name: Adverse Report (Examination) correspondence sent
15) Date: 2025-06-25
Display name: IP Right has been Examined
16) Date: 2025-06-11
Display name: IP Right Filed correspondence sent
17) Date: 2025-06-11
Display name: Awaiting examination
18) Date: 2025-06-11
Display name: Examination expedited
19) Date: 2025-06-11
Display name: IP Right Filed Published
20) Date: 2025-06-11
Display name: Status change to Published
21) Date: 2025-06-11
Display name: Status change to Filed
22) Date: 2025-06-11
Display name: Trade mark representation updated
23) Date: 2025-06-11
Display name: Application Received
Owner Information
Owner structured address:
Suite 803, Level 8, Tower A, The Zenith 821 Pacific Highway, Chatswood, NSW, AUSTRALIA, Postal Code: 2067
Owner is private:
0
Service Information
Address Acn:
620368729
Address structured address:
Level 3, 32 Martin Place,, Sydney, NSW, AUSTRALIA, Postal Code: 2000
Address is private:
0